Key result
Hypoxia promotes NSCLC cell proliferation, migration, and invasion via the Akt-PDK1-HIF1α-YKL-40 pathway.
Why the study?
Hypoxia promotes growth and angiogenesis in NSCLC, but the specific molecular pathway involving Akt-PDK1-HIF1α-YKL-40 requires verification.
Hypoxia promotes non-small cell lung carcinoma cell expansion and angiogenesis through the Akt-PDK1-HIF1α-YKL-40 pathway, identifying a potential interventional target for anti-vascular lung cancer therapy.
May support pathway inhibition as anti-angiogenic strategy in NSCLC; hypothesis-generating in animal models and requires clinical validation.
BACKGROUND: As one of the most common forms of cancer, non-small cell lung carcinoma (NSCLC), is characterized by oxygen deprivation (hypoxia). The transcription factor hypoxia-inducible factor (HIF)-1α is a major mediator which responds hypoxia and regulates many contributing factors. The various modes of hypoxia regulation are frequently the focus of research studies. With reference to previous published research, we hypothesized that hypoxia promotes the growth and angiogenesis of NSCLC via the Akt-PDK1-HIF1α-YKL-40 pathway, and verified it. METHODS: We mainly investigated changes in related factor expression between differently treated CL1-5 cells. We carried out overexpression and underexpression transfection, Western blot, rt-PCR and ELISA, and observed cellular biological behaviors by CCK-8 migration and invasion assay, and tube formation assay. RESULTS: A hypoxic environment significantly increased the phosphorylation of Akt and PDK1 in mitochondria. The hypoxia-induced accumulation of p-Akt in mitochondria activated PDK1 phosphorylation, promoted the expression of HIF1α, and the expression of YKL-40. The overexpression of YKL-40 promoted the proliferation, migration, invasion and tubule formation of CL1-5 cells. CONCLUSIONS: A hypoxic tumor microenvironment can promote the expansion and angiogenesis of NSCLC cells through the Akt-PDK1-HIF1α-YKL-40 pathway. This may provide a new mechanism and potential interventional target for anti-vascular lung cancer therapy.
No takes yet. Share an insight, caveat, or question.
Miao et al. (2020) studied non-small cell lung carcinoma (NSCLC). Hypoxia was evaluated on Expression of Akt, PDK1, HIF1α, YKL-40 and cellular biological behaviors (proliferation, migration, invasion, tubule formation). Hypoxia promoted the proliferation, migration, invasion, and tubule formation of NSCLC cells via the Akt-PDK1-HIF1α-YKL-40 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: